Several studies reported that RAD51 overexpression was associated with poor prognosis in various cancers such as non-small-cell lung carcinoma, head cancers, esophageal squamous cell carcinoma, breast cancer, melanoma, and CRC [19-24]. This evidence concerns the gene RAD51 and melanoma.